Clinical Trial Update: Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability and immunogenicity of the MVA-MERS-S vaccine candidate for Middle East Respiratory Syndrome completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle East Respiratory Syndrome

Drugs mentioned

• MVA-MERS-S (MVA-MERS-S)

Snippet

Sponsor: Marylyn Addo | Conditions: MERS (Middle East Respiratory Syndrome) | Phase 1 | Status: COMPLETED | Results posted: 2020-10-06